"Glaucoma is a group of diseases that damage the optic nerve, a cable at the back of each eye that connects it to the brain. It affects more than 2.7 million people in the United States and more than 60 million worldwide. There are many forms of t"...
CYSTARAN is a cystine-depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
DOSAGE AND ADMINISTRATION
Instill one drop of CYSTARAN in each eye, every waking hour.
Do not touch dropper tip to any surface, as this may contaminate the solution.
Discard after 1 week of use.
Dosage Forms And Strengths
Sterile ophthalmic solution containing 6.5 mg/mL of cysteamine hydrochloride equivalent to 4.4 mg/mL of cysteamine (0.44%).
Storage And Handling
CYSTARAN (cysteamine ophthalmic solution) 0.44% is supplied in a 15 mL, opaque, white, low-density polyethylene (LDPE) bottle with a 15 mm white, LDPE controlled dropper tip and closed with a white, polypropylene screw cap.
Store in freezer at -25°C to -15°C (-13°F to 5°F). Thaw for approximately 24 hours before use. Store thawed bottle at 2°C to 25°C (36°F to 77°F) for up to 1 week. Do not refreeze. Discard after 1 week of use.
Manufactured by: Hi-Tech Pharmacal, Co., Inc., Amityville, NY 11701 for sigma-tau, Pharmaceuticals, Inc, Gaithersburg, MD 20878. Revised: 10/2012This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/11/2012
Additional Cystaran Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.